Musellarin A is primarily studied for its potential anti-inflammatory and neuroprotective properties. It has shown activity in modulating pathways associated with oxidative stress, making it a compound of interest in research related to neurodegenerative diseases such as Alzheimer's and Parkinson's. Its ability to inhibit certain pro-inflammatory cytokines suggests possible application in developing treatments for chronic inflammatory conditions. Additionally, Musellarin A has demonstrated mild antioxidant effects, which may contribute to cellular protection against damage caused by free radicals. Current applications remain within preclinical research, focusing on understanding its mechanism of action and therapeutic potential.